Last reviewed · How we verify
dacomitinib fasted
At a glance
| Generic name | dacomitinib fasted |
|---|---|
| Sponsor | Pfizer |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Dacomitinib (PF-00299804) Pharmacokinetics In Chinese Healthy Volunteers (PHASE1)
- Evaluation Of The Potential Effect That The Administration Of Food Or Antacid Medication May Have In The Oral Absorption Of Dacomitinib (PF-00299804) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- dacomitinib fasted CI brief — competitive landscape report
- dacomitinib fasted updates RSS · CI watch RSS
- Pfizer portfolio CI